The subject has a history of allergy or intolerance to flucytosine
No known allergy to aspirin
Patients must not have prior history of allergy or known hypersensitivity to nivolumab or ipilimumab
Known allergy to boron or excipients in the formulation
Patients with known allergy to mitoxantrone, cytarabine, or both etoposide and etoposide phosphate (Etopophos)
Patient has history of allergy to any oily drug products
Patients with a known or documented anaphylactic reaction or allergy to any of chemotherapy agents used in this protocol, or to antiemetics appropriate for administration in conjunction with protocol-directed therapy
Known allergy to any of the study agents
Known allergy to enadenotucirev, nivolumab or their excipients
Known history of positive serum human anti-drug antibody (ADA), or known allergy to any component of ADCT-301
Prior allergy or adverse reaction to methotrexate
No known allergy or adverse reaction (e.g., wound dehiscence) to poly-lactide-co-glycolide (PLG)
Known allergy to egg products or soy bean oil
Significant allergy to a pharmaceutical therapy that, in the opinion of the Investigator, poses an increased risk to the patient
A history of a severe contrast allergy (i.e. anaphylaxis) not controlled with premedication
Known allergy/intolerance to soy, phosphatidylcholine or any other constituents of grape seed extract
Patients with a latex allergy
Known in tolerance and allergy to cytarabine.
Previous known allergy or intolerance to pembrolizumab or any of its excipients
Previous exposure or known allergy to Imprime PGG or any of its excipients
Known allergy to grapes or grape seed
Have known allergy to ovalbumin or other egg products
Allergy to benzamide or inactive components of entinostat.
Previous history of hypersensitivity to eggs or allergy or untoward reaction to prior vaccinia (smallpox) vaccination
Bovine product allergy
Allergy to measles vaccine or history of severe reaction to prior measles vaccination
Allergy to shellfish
Milk allergy
Known history of contrast allergy that cannot be medically managed
EXCLUSION - TREATMENT: Known allergy to VZV vaccine
Known allergy to HCQ
Known allergy to eggs, egg products, aminoglycoside antibiotics (for example, gentamicin or tobramycin)
Patients with known allergy or hypersensitivity to AG120 or venetoclax.
Doxycycline allergy
Allergy or intolerance to roflumilast
Known allergy to PEGylated products
Participants must not have a history of allergy to nivolumab, urelumab or cabiralizumab
History of gastritis or malabsorption syndrome or aspirin intolerance or allergy
Patients with a history of allergy to medications that have a benzamide structure (e.g., metoclopramide, procarbazine, domperidone, cisapride etc.) are not eligible
Bupivacaine or liposomal bupivacaine sensitive or known allergy.
Known allergy to eggs, egg products, aminoglycoside antibiotics (e.g. gentamicin or tobramycin)
Known allergy to anthracyclines.
Allergy to any component of MSC suspension (such as human albumin) and/or allergy to any drugs used in HCT conditioning regimen
History of allergy to merestinib or chemically related compounds
An allergy or intolerance to egg, gluten or milk protein
Subject has known history of allergy, hypersensitivity, or any serious reaction to any of the azole class antifungals.
Patient has a history of allergy to red color food dye or any other component of Qapzola, placebo, or their diluents
Allergy to benzamide or inactive components of entinostat
Known allergy or hypersensitivity to IP
Known allergy, or history of serious adverse reaction to vaccines such as anaphylaxis, hives, or respiratory difficulty
Known allergy or hypersensitivity to intraperitoneal (IP) or any excipient
Known allergy, or history of serious adverse reaction to vaccines such as anaphylaxis, hives, or respiratory difficulty
Known allergy to grapes or grape seed
Patients with unconfirmed allergies to piperacillin-tazobactam, cefepime, aztreonam or vancomycin can be evaluated by an allergy/immunology specialist, after which they may become eligible by a consensus of the treating physician, trial investigator and the allergy/immunology specialist
Patients with a known allergy to Zometa or to antiemetics appropriate for administration in conjunction with protocol-directed therapy
Known allergy or intolerance to lidocaine
Patients with a known hypersensitivity/allergy to any of the standard of care agents used in this study or related compounds (e.g. platinum compounds) are excluded
Gadolinium allergy
Patients with an allergy, or have experienced any drug reaction to ketamine will be excluded
Allergy to benzamide or inactive components of entinostat
Known allergy to coenzyme Q10
Known allergy or adverse reaction to oral, subcutaneous, or intravenous vitamin K
Known allergy to doxycycline or tetracycline
Known allergy to ODM-201 or any of the excipients.
History of severe allergy (e.g., anaphylaxis) to any component of Prevnar or any diphtheria?toxoid containing vaccine
Patients with known allergy to cremophor or polysorbate 80
Known allergy to PIO
Allergy to measles vaccine or history of severe reaction to prior measles vaccination
Allergy or hypersensitivity to agents used within the treatment protocol
Known allergy to eggs, egg products, aminoglycoside antibiotics (for example, gentamicin or tobramycin)
Patients who have known allergy to mebendazole
DONOR: Known allergy or hypersensitivity to any of the test compounds, materials, or contraindication to test products
Patient has a history of allergy or intolerance to flucytosine.
Patients with known carboplatin or cisplatin allergy
Known allergy or hypersensitivity to any of the test compounds, materials or contraindication to test product.
Known allergy to sulfa or specific allergy to sulfonylurea drugs
Allergy to gadolinium
Known allergy, hypersensitivity or prior infusion reaction to one or more of the therapies incorporated into this treatment protocol
Patients with a known allergy to cisplatin chemotherapy; patients with carboplatin allergy may be included if they tolerate a test dose of intravenous (IV) cisplatin given in monitored floor conditions
Known allergy, or history of serious adverse reaction to vaccines such as anaphylaxis, hives, or respiratory difficulty
Allergy to filgrastim, pegfilgrastim, or loratadine
Patients must not have a known history of yeast allergy; if patient has a questionable history of allergy to yeast, a yeast skin test can be performed; patients would be eligible if skin test is negative (note, patients may not be on tricyclic antidepressants at the time of yeast skin test)
Known allergy, or history of serious adverse reaction to vaccines such as anaphylaxis, hives, or respiratory difficulty
Gold allergy
Known history of allergy to Captisol®
Patients with known allergy, intolerance, or resistance (i.e., remission duration less than 6 months or lack of response) to ifosfamide, carboplatin, or etoposide
Known allergy, or history of serious adverse reaction to vaccines such as anaphylaxis, hives, or respiratory difficulty
Patients with a known allergy to dimethyl sulfoxide (DMSO)
Patients with a known history of allergy to soy products
MAIN STUDY COHORT EXCLUSION CRITERIA: History of other malignancy with concern for renal metastasis and known allergy to technetium or sestamibi
Subjects with known allergy to lidocaine, epinephrine, itraconazole or petrolatum
Allergy to measles vaccine or history of severe reaction to prior measles vaccination
History of allergy to penicillin or related antibiotic
Patients with an allergy or known hypersensitivity to fish
Known allergy to any of the agents or their ingredients used in this study
Allergy to oseltamivir or excipients
Known allergy to domperidone
Known severe or life-threatening allergy or intolerance to fludarabine, alemtuzumab, cyclosporine, or mycophenolate mofetil.
Patients with latex allergy.
Patients who have an allergy to gold.
Corn allergy
History of allergy to KLH, QS-21, OPT-821, or glucan
History of severe allergy or intolerance to any contrast media, narcotics, sedatives, or atropine, that cannot be controlled using basic angiographic techniques
History of severe allergy or intolerance to any contrast media, narcotics, sedatives, or atropine, that cannot be controlled using basic angiographic techniques
History of photosensitizing disease (porphyria, lupus etc.) or of allergy to methylene blue dye.
Patients are excluded if there is any history of gadolinium allergy.
Patient having known allergy to NSAID or Aspirin
Known allergy to doxorubicin or anthracyclines.
History of allergy or hypersensitivity to the device constituent or Inserter materials.
Subjects with hypersensitivity or allergy to tetracycline antibiotics or edetate disodium;
History of allergy or hypersensitivity to any of the study drugs.
Patient has a prior allergy or intolerance of ketoconazole
Patient has an allergy or intolerance to sulfites
Patients with known allergy to MB
Known allergy(ies) to any component of CMB305 or LV305.
Known allergy, or history of serious adverse reaction to, vaccines such as anaphylaxis, hives, or respiratory difficulty.
Allergy to measles vaccine or history of severe reaction to prior measles vaccination
Known allergy to hyaluronidase
Allergy to measles vaccine or history of severe reaction to prior measles vaccination
Allergy to measles vaccine or history of severe reaction to prior measles vaccination
Patients with prior allergy to daunorubicin and/or cytarabine
Patients who have an allergy/intolerance to sirolimus
DONOR: Known allergy to filgrastim (GCSF)
Allergy to measles vaccine or history of severe reaction to prior measles vaccination
Allergy to or intolerance of prior doxorubicin-based TACE
Known history of allergy to Captisol®
Soy allergy
History of allergy or untoward reaction to prior vaccination with vaccinia virus
Known history of positive serum human ADA, or known allergy to any component of ADCT-301.
Known allergy(ies) to any component of CMB305 or CPA
Patients with known floxuridine, leucovorin (leucovorin calcium), or mitomycin (mitomycin C) allergy
Known allergy to boron, MLN9708, any of the study treatments, their analogues, or excipients.
History of severe peripheral allergy or intolerance to contrast agents, narcotics, sedatives or atropine that cannot be managed medically
Known allergy to both penicillin and sulfa antibiotics
No known allergy to platinum compounds
History of severe allergy or intolerance to contrast agents, narcotics sedatives or atropine that cannot be managed medically
Known allergy to latex or gadolinium (Gd).
Allergy to ciprofloxacin (or other quinolones), acetylsalicylic acid, or indomethacin.
Known allergy, or history of serious adverse reaction to, vaccines such as anaphylaxis, hives, or respiratory difficulty
Known allergy(ies) to any component of the study agent GLA-SE including egg lecithin
Have a known allergy to tomatoes or have never consumed tomatoes
Known allergy to thalidomide.
Known allergy to ovalbumin or other egg products
Allergy to ganciclovir or acyclovir
Known allergy to eggs, egg products, aminoglycoside antibiotics (for example, gentamicin or tobramycin)
Known allergy to both penicillin and trimethoprim/sulfamethoxazole. Participants who are allergic to only one of these antibiotics are allowed to enroll
Patient has a history of allergy to red color food dye.
A known allergy to any component of LY2157299.
Known allergy to hyaluronidase
Allergy to meclofenamate or other nonsteroidal antiinflammatory drug (NSAID)
Patients with documented allergy to cephalosporins
Has allergy to enzalutamide
Patient has a known allergy to both penicillin and sulfa
All patients who have received prior vaccination with vaccinia virus (for smallpox immunization) must not have a history of allergy to the vaccine
Patients with known allergy to eggs
Known history of allergy to Captisol
Allergy to soy, egg, or peanut products
Patients with a known allergy to murine proteins or have had a documented anaphylactic reaction or allergy to any of chemotherapy agents used in this protocol, oregovomab, or to antiemetics appropriate for administration in conjunction with protocol-directed therapy
Known allergy to any of the drugs used in the study. (Subjects who have had a previous allergy to PEG-asparaginase but can receive Erwinia are eligible.)
Known allergy attributed to bupropion, varenicline, transdermal or lozenge nicotine
Known allergy to eggs, egg products, aminoglycoside antibiotics (for example, gentamicin or tobramycin)
Known allergy to eggs, egg products, aminoglycoside antibiotics (for example, gentamicin or tobramycin)
Known allergy to any of the study medications
A known allergy to any component of the HyperAcute®-Lung immunotherapy or cell lines from which it is derived.
Patients who have known allergy to mebendazole or benzimidazole
Allergy or hypersensitivity to agents used within the treatment protocol
Known allergy to any of the compounds under investigation
Have a known allergy to resiquimod or any of the excipients in the study drug
Medically diagnosed lactose intolerance, lactose allergy or salicylate allergy
If patients meet any of the following they will be excluded:\r\n* Active infection requiring intravenous treatment or having an unexplained febrile illness (temperature maximum [Tmax] > 99.5 Fahrenheit [F]/37.5 Celsius [C])\r\n* Known immunosuppressive disease or known human immunodeficiency virus infection\r\n* Unstable or severe intercurrent medical conditions such as severe heart (New York Heart Association class 3 or 4) or known lung (forced expiratory volume in 1 second [FEV1] < 50%) disease, uncontrolled diabetes mellitus\r\n* Albumin allergy; patients with a known allergy will be excluded\r\n* Gadolinium allergy
Known allergy to gadolinium
Known or suspected allergy to pazopanib
18F FLT CANDIDATE TRANSPLANT RECIPIENT: History of prior fluorothymidine allergy or intolerance
Subjects with known allergy or hypersensitivity to doxorubicin, cyclophosphamide, or eribulin mesylate.
History of allergy to platinum compounds or to antiemetics appropriate for administration in conjunction with protocol-directed chemotherapy
Known or suspected allergy to ARQ 197
Allergy to benzamide or inactive components of entinostat
Patients with a history of allergy to entinostat or other medications that have a benzamide structure (i.e. tiapride, remoxipride, and clebopride)
Known allergy to allopurinol for subjects assessed with PR following their second-line induction therapy.
Patients with a known allergy to any component of vorinostat, or a known allergy to temozolomide and/or isotretinoin.
Patients with known allergy to etoposide or a history of grade 3 hemorrhagic cystitis with cyclophosphamide are not eligible
DONOR: Known allergy to G-CSF
Patients will be excluded if they have a known allergy to any of the drugs used in the study
Allergy to measles vaccine or history of severe reaction to prior measles vaccination.
Known allergy to bone cement,
Patients will be excluded if they have a known allergy to any of the drugs used in the study.
Any known allergy to the compounds under investigation
Patients with known allergy or hypersensitivity to IMGN901
Known allergy to wheat, rice (contained in the placebo), orange or the sweetener, Stevis
Known allergy to hyaluronidase or any constituents of docetaxel formulation.
Bovine product allergy
Known allergy to any of the study drugs
Prior history of penicillin or streptomycin allergy
Known intolerance or allergy to medications used for sedation (midazolam), analgesia (fentanyl), and local and regional anesthesia (lidocaine, bupivacaine, and ropivacaine)
Patients with a soy allergy will be excluded
History of severe allergy or intolerance to contrast agents, narcotics, sedatives or atropine that cannot be managed medically
Known or suspected allergy to the investigational agents or any agent given in association with this trial (hypersensitivity reaction, hives, rash, difficulty breathing swelling of your face, lips, tongue, or throat)
Patient has a history of allergy or hypersensitivity to the study drugs
The subject has a known allergy to tetracycline
Patient has a history of allergy or hypersensitivity to the study drugs
Known allergy to macrolide antibiotics
Known allergy to any of the study agents
Allergy to either of the study medications or 5-fluorouracil
Nut allergy
Patient has a known allergy to bovine or porcine products.
Known allergy or history of adverse reaction to Blue dye (Isosulfan blue) or triphenylmethane.
Known allergy to any of the components used during vertebroplasty (polymethyl methacrylate [PMMA] bone cement)
Patient who has a history of allergy or hypersensitivity to any of the study drugs
Does the subject have a history of allergy or intolerance to flucytosine?
Known allergy to treatment medication (vemurafenib)
Known allergy or hypersensitivity to any of the test compounds, materials or contraindication to test product.
Known allergy to study medications
History of significant drug-related allergy (such as anaphylaxis)
Patients with known allergy/hypersensitivity to warfarin or bupropion and/or related compounds
Known allergy to doxycycline or other tetracycline antibiotics
History of allergy to Urelumab (BMS-663513) or related compounds
History of significant drug allergy (such as anaphylaxis or hepatotoxicity) to a prior biologic therapy
Known allergy to any of the study medications
allergy or intolerance to 5-FC
Allergy: known hypersensitivity to other recombinant human antibodies
Known allergy to eggs
Allergy to gadolinium
Known allergy to any of the agents or their ingredients used in this study
Allergy to bupropion
Known allergy to adhesive tape
Known or suspected allergy to pamidronate or related products
Known allergy to EACA
Allergy to allopurinol
known allergy to both penicillin and sulfa drugs
Allergy to egg or egg byproducts
Known history of allergy or intolerance to montelukast, zafirleukast, azithromycin, erythromycin, clarithromycin, prednisone, or sirolimus
Allergy to botulinum toxin, and or egg
Fish and/or fish oil allergy or intolerance
Milk allergy excluding lactose intolerance
Allergy or intolerance to bupivacaine or “amide” anesthetics
Known allergy to soy or any soy-based food or supplement
Known allergy to local anesthetics
Known allergy to perampanel
Known allergy to or prior intolerance of aspirin and/or simvastatin
History of an allergy to romiplostim
Allergy treatment with antigen injections
Allergy or adverse reaction to local anesthesia catheter
Known true tape allergy
No known allergy to ingredients of banana bread preparation (eggs, almonds and other nuts since the celery also has almond powder)
Known allergy to stevia
Allergy or intolerance to 5HT3 or NK-1 antagonists and dexamethasone
Allergy treatment with antigens injections
Patients with a known allergy or hypersensitivity to CHG are ineligible
Patients with an allergy to quinolones
Patients must have no known allergy or hypersensitivity to duloxetine or any of the inactive ingredients in the matching placebo
Known allergy to a probiotic preparation
Food allergy to any component of the supplement
History of allergy to investigational agent: ropivacaine or other amino amide analgesics
History of allergy to standard agent: propofol
Allergy to gabapentin
No known allergy to diphenhydramine, lidocaine, antacid (aluminum hydroxide, magnesium hydroxide, and simethicone), doxepin, tricyclic antidepressants, or any known component of the drug formulation in the testing arms
Antibiotic allergy to study medication
Allergy to bone morphogenetic protein
Allergy to bovine collagen products
Known allergy to both penicillin and trimethoprim/sulfamethoxazole. Participants who are allergic to only one of these antibiotics are allowed to enroll
Patients with documented allergy to egg products.
Patients with documented allergy to soy products.
Previous intolerance/adverse effect/allergy to any component of the placebo or active agent
Allergy to beef
Participant has a known allergy to melatonin or any ingredients of the study product or placebo
Patients must not have an allergy to latex
Patients with history of allergy or adverse reactions to sodium bicarbonate or normal saline
No known allergy to either ACE inhibitors or ?-blockers
Known allergy to phenylephrine
Doxycycline allergy
Allergy to sugar substitute
Allergy to gabapentin
Allergy to either Eucerin or MF
Known allergy or preexisting skin disease which prohibits use of menthol
Patients with a history of allergy or adverse reaction to corticosteroids
Known allergy to a probiotic preparation
Allergy or intolerance to gadolinium
Participants who have a known allergy to contrast media.
Participants who have a known allergy to contrast media
History of allergy to acetic acid
History of allergy to apixaban or Factor Xa inhibitors
History of any significant drug allergy (such as anaphylaxis or hepatotoxicity
Known allergy to electrode adhesives or woven knit compression fabrics
RECIPIENT: Allergy treatment with antigens injections
Known allergy to LCM or LEV
Known history of allergy to any component or other contraindications to any Neurokinin-1 (NK1) or 5-hydroxytryptamine 3 (5-HT3) receptor antagonists.
Individuals with a known allergy to lidocaine are not eligible
History of allergy or intolerance to ISA
History of allergy to eggs, egg products, aminoglycoside antibiotics
Women with an allergy to rapamycin or its derivatives
Have a known allergy or food intolerance to ingredients in study products (black raspberries or other berries)
Documented allergy to apixaban and/or enoxaparin
Allergy to nicotine patch, nicotine lozenge, or varenicline
Patient has allergy to fish or is a vegetarian
Patients who have an allergy to eggs
Known allergy to eggs, egg products
Bovine product allergy.
Subjects with a known allergy to lidocaine
Patients with an allergy to Peridex/chlorhexidine solution
Any serious egg allergy or prior serious adverse reaction to an influenza vaccine
Has a history of significant allergy to calcitriol as determined by the investigator.
Has known allergy to Tc99m sestamibi
Iodide or seafood allergy
Women with a known allergy to proflavine or acriflavine
Known allergy to adhesive tapes or other skin adhesives used in medical care
Allergy to sulfa or sulfa-containing medications
Allergy to sulfa or sulfa-containing medications
History of allergy to iodide drugs or shellfish (iodine allergy)
Prior history of hypersensitivity to pegylated liposomal doxorubicin or indocyanine green (ICG) allergy; caution should be taken if prior ICG allergy is noted
Patients with a known allergy to Benadryl
Known allergy to gadolinium or the sedative, propofol, used during MRI
Subjects with established allergy to IV GBCA
Patients with history of allergy to hydrogel dressing or ongoing skin diseases
Has known allergy to Tc 99m sestamibi
Participants who have a known allergy to contrast media
History of prior fluorothymidine allergy or intolerance
Women with a known allergy to proflavine or acriflavine
Patients with allergy to regadenoson
Known allergy or anaphylactic reaction to indocyanine green (ICG).
Severe food or medication allergy
Known allergy to proflavine or acriflavine
History of multiple food and/or drug allergy
No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredients in the test products as determined by the dental/medical professional monitoring the study
History of significant adverse effects following use of oral hygiene products such as toothpastes and mouth rinses; allergy to personal care/consumer products or their ingredients
Has a known allergy to dextran or VBD (if intended to be used)
Known allergy to gadolinium.
No allergy to gadolinium
History of any anaphylactic reaction, any severe allergy, or any allergy to folate
Has a known allergy to dextran
Known allergy to FdCyd
Allergy to fluoroquinolones
Allergy to any component of sipuleucel-T
Allergy to Brussels sprouts
Nut or seed allergy
No known allergy to tree nuts
Participant must not have a history of allergy to erlotinib
